EMA-CO方案与5-Fu+KSM方案治疗恶性滋养细胞肿瘤临床比较.doc

EMA-CO方案与5-Fu+KSM方案治疗恶性滋养细胞肿瘤临床比较.doc

  1. 1、本文档共11页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
EMA-CO方案与5-FuKSM方案治疗恶性滋养细胞肿瘤临床比较

EMA-CO方案与5-Fu+KSM方案治疗恶性滋养细胞肿瘤临床比较   摘要:目的:研究EMA-CO方案与5-Fu+KSM方案治疗恶性滋养 细胞肿瘤的疗效及化疗副反应 。方法:采用EMA-CO方案治疗恶性滋养细胞肿瘤25例与5-F u+KSM方案治疗恶性滋养细胞肿瘤21例。结果:EMA-CO方案治疗恶性滋养细胞肿瘤25例总完 全缓 解率为88.00%,耐药绒癌的完全缓解率为88.88%,复发性妊娠恶性滋养细胞肿瘤的完全缓解 率为100%。化疗副反应主要为Ⅰ~Ⅱ级恶心、呕吐和骨髓抑制。5-Fu+KSM方案治疗恶性滋养 细胞肿瘤21例总完全缓解率为80.95%。化疗副反应主要为Ⅲ~Ⅳ级恶心、呕吐和骨髓抑 制明显,消化道反应重,有时会发生严重的口腔溃疡,腹泻。结论:采用EMA-CO方案治疗妊娠 恶性滋养细胞肿瘤疗效满意,对其他药物耐药或复发病例也可获得满意的疗效,化疗副反应轻 , 患者易接受,可作为临床一线用药。在患者合并肺转移,形成阻塞性肺炎,高热不退的情况 下,仍可使用EMA-CO方案化疗。   关键词:恶性滋养细胞肿瘤;化疗;副反应   中图分类号: R737.33 文献标识码: A 文章编号: 1008-2409(2008)05-0913-03      A clinical comparison ofEMA-CO protocol for treatment of m alignant trophoblas tic tumor with 5-Fu+KSM protocol/TANG Xiong-zhi,LUO Zhao-qin∥The Peopl es Hospital of Guilin City, Guilin 541002, China   Abstract: Objective:To compare the effectivenss and side effects of EMA-CO protoc ol for treatment of m alignant trophoblastic tumor with 5-Fu+KSM protocol. Metho ds:The clinical record of 25 patients treated by EMA-CO protocol and 21 patient streated by 5-Fu+KSM protocol from january, 2002 to october,2007 in the PeopleHo spital of Guilin city were reviewed. Results:25 patients(88.00%) achieved comple te remi ssion by EMA-CO. The complete remission of recurrent m alignant trophoblastic tu m or cases was 100%, and of chemotherapy resistant choriocarcinoma cases was 88.8 8% .The major side effects were medium or low-grad nausea, vomiting and marrow sup pr ession. 21 patients(80.95%) achieved complete remission by 5-Fu+KSM proto col. The major side effects were Ⅲor Ⅳgrad nausea, vomiting, marrow suppress ion, oral cavity ulcer, and diarrbea. Conclusions:For m alignanttrophoblastictumor, the EMA-CO protocol could achieve satisfatory effects as the primary the rapy, and obtain good result for the chemotherapy resistant and recurrent cases. EMA-CO presents mild side effects and is easyto beaccepted bythe patients .EMA-CO protocol could be used as the primary therapy. If the tumor metasta s izes to lung, causes to pneumonia, a high fever EMA-

您可能关注的文档

文档评论(0)

189****7685 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档